Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in Arch Bronconeumol

Retrieve available abstracts of 92 articles:
HTML format



Single Articles


    November 2022
  1. MADRID CARBAJAL C, Palomo B, Garcia Clemente M
    Radiological Changes After Treatment With Triple Therapy in Cystic Fibrosis. Are Bronchiectasis Irreversible?
    Arch Bronconeumol. 2022 Nov 5:S0300-2896(22)00599.
    PubMed    


  2. CALLE RUBIO M, Lopez-Campos JL, Izquierdo Alonso JL, Martinez Pitarch D, et al
    Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group.
    Arch Bronconeumol. 2022;58:776-779.
    PubMed    


  3. ROMERO-FALCON MA, Medina-Gallardo JF, Lopez-Campos JL, Maestre Sanchez MV, et al
    Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study.
    Arch Bronconeumol. 2022 Nov 1. pii: S0300-2896(22)00596.
    PubMed     Abstract available


    October 2022
  4. FIGUEIRA-GONCALVES JM, Golpe R
    Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients.
    Arch Bronconeumol. 2022;58:729-730.
    PubMed    


  5. MONTEAGUDO M, Nunez A, Barrecheguren M, Miravitlles M, et al
    Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study.
    Arch Bronconeumol. 2022;58:699-707.
    PubMed     Abstract available


  6. MARTIN-ONTIYUELO C, Rodo-Pin A, Echeverria-Esnal D, Admetllo M, et al
    Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial.
    Arch Bronconeumol. 2022;58:689-698.
    PubMed     Abstract available


    September 2022
  7. ALVAREZ-GUTIERREZ FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, et al
    What's New in the 2022 Consensus for Severe Asthma in Adults.
    Arch Bronconeumol. 2022 Sep 28. pii: S0300-2896(22)00575.
    PubMed    


  8. DIAB CACERES L, Morales Ruiz R, Villena Garrido V
    Does Bronchiectasis Cause Irreversible Damage?
    Arch Bronconeumol. 2022 Sep 27. pii: S0300-2896(22)00576.
    PubMed    


  9. SOLARAT B, Perea L, Faner R, de La Rosa D, et al
    Pathophysiology of Chronic Bronchial Infection in Bronchiectasis.
    Arch Bronconeumol. 2022 Sep 15. pii: S0300-2896(22)00525.
    PubMed     Abstract available


  10. SADATSAFAVI M, Aaron SD, Gershon AS, Puhan M, et al
    The Hidden and Unchecked Judgement Calls When Using Exacerbation History for Managing COPD.
    Arch Bronconeumol. 2022;58:629-631.
    PubMed    


  11. GONZALEZ J, Carmona P, Gracia-Lavedan E, Benitez ID, et al
    Cluster Analysis of Home Mechanical Ventilation in COPD Patients: A Picture of the Real World and Its Impact on Mortality.
    Arch Bronconeumol. 2022;58:642-648.
    PubMed     Abstract available


  12. RODRIGO-TROYANO A, Giner J, Perea L, Merino JL, et al
    Predicting Early Hospital Readmissions in COPD Patients Using an Electronic Nose.
    Arch Bronconeumol. 2022;58:663-665.
    PubMed    


    August 2022
  13. COSIO BG, Shafiek H, Martinez-Garcia MA
    Is it Time to Readjust the Doses of Inhaled Corticosteroids in COPD?
    Arch Bronconeumol. 2022;58:593-594.
    PubMed    


  14. ALCAZAR-NAVARRETE B, Diaz-Lopez JM, Garcia-Flores P, Ortega-Antelo M, et al
    T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:595-600.
    PubMed     Abstract available


  15. SU KC, Ko HK, Hsiao YH, Chou KT, et al
    Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial.
    Arch Bronconeumol. 2022;58:601-610.
    PubMed     Abstract available


  16. SORIANO JB, Dai X, Ancochea J
    An Euler Proportional Venn Diagram of Obstructive Lung Disease.
    Arch Bronconeumol. 2022;58:627-628.
    PubMed    


    July 2022
  17. KUNADHARAJU R, Rudraraju A, Sethi S
    Pseudomonas aeruginosa Colonization and COPD: The Chicken or the Egg?
    Arch Bronconeumol. 2022;58:539-541.
    PubMed    


    June 2022
  18. XU JF, Gao YH, Guan WJ
    Advances in Bronchiectasis Registries: The New Chinese Registry.
    Arch Bronconeumol. 2022 Jun 11. pii: S0300-2896(22)00447.
    PubMed    


  19. KATSOULIS K, Kipourou M, Quaranta Vitaliano N, Kostikas K, et al
    Predicting Bronchial Hyperresponsiveness in Patients with Asthma: The Role of Impulse Oscillometry.
    Arch Bronconeumol. 2022 Jun 2. pii: S0300-2896(22)00438.
    PubMed    


  20. LONG MB, Chalmers JD
    Treating Neutrophilic Inflammation in Airways Diseases.
    Arch Bronconeumol. 2022;58:463-465.
    PubMed    


  21. MANISCALCO M, Fuschillo S, Ambrosino P, D'Anna SE, et al
    Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients.
    Arch Bronconeumol. 2022;58:517-519.
    PubMed    


  22. LUIS IZQUIERDO J, Casanova C, Celli B, Santos S, et al
    The 7 Cardinal Sins of COPD in Spain.
    Arch Bronconeumol. 2022;58:498-503.
    PubMed     Abstract available


  23. GARCIA-VALERO J, Olloquequi J, Rodriguez E, Martin-Satue M, et al
    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
    Arch Bronconeumol. 2022;58:482-489.
    PubMed     Abstract available


  24. MARCOS PJ, Represas Represas C, Ramos C, Cimadevila Alvarez B, et al
    Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.
    Arch Bronconeumol. 2022;58:474-481.
    PubMed     Abstract available


    May 2022
  25. PASCUAL S, Dorado S, Urrutia I
    Physical Activity and Asthma.
    Arch Bronconeumol. 2022 May 17. pii: S0300-2896(22)00342.
    PubMed    


  26. SCIOSCIA G, Alcaraz-Serrano V, Mendez R, Gabarrus A, et al
    Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
    Arch Bronconeumol. 2022 May 13. pii: S0300-2896(22)00336.
    PubMed    


  27. MARTINEZ-GONZALEZ C, Garcia JA, Blanco I
    [Translated article] Term Pregnancy in a Patient With Severe Pulmonary Emphysema Associated With Pi*ZZ Alpha-1 Antitrypsin Deficiency.
    Arch Bronconeumol. 2022 May 5. pii: S0300-2896(22)00311.
    PubMed    


  28. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    [Translated article] Asthma Also Exists in Older People.
    Arch Bronconeumol. 2022 May 4. pii: S0300-2896(22)00312.
    PubMed    


  29. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:T451-T453.
    PubMed    


  30. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:412-417.
    PubMed     Abstract available


  31. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    [Translated article] Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:T433.
    PubMed    


  32. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    [Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:T412-T417.
    PubMed     Abstract available


  33. PEREZ PEREZ JL, Garcia-Manso IG, Garcia Sevila R
    [Translated article] Acute Fibrinous and Organizing Pneumonia Associated With Immunotherapy (Pembrolizumab).
    Arch Bronconeumol. 2022;58:T425-T426.
    PubMed    


  34. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:T386-T387.
    PubMed    


  35. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    [Translated article] Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:T454-T456.
    PubMed    


  36. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:442-443.
    PubMed    


  37. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:433.
    PubMed    


  38. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:386-387.
    PubMed    


  39. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:T442-T443.
    PubMed    


  40. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:454-456.
    PubMed    


  41. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:451-453.
    PubMed    


    April 2022
  42. NAVAS-BUENO B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, et al
    High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study.
    Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00320.
    PubMed    


  43. CHINER-VIVES E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, et al
    Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Arch Bronconeumol. 2022;58 Suppl 1:39-50.
    PubMed     Abstract available


  44. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    [Translated article] The ANTES Program in COPD: First Year.
    Arch Bronconeumol. 2022;58:T291-T294.
    PubMed    


  45. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?
    Arch Bronconeumol. 2022;58:T364-T366.
    PubMed    


  46. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:334-344.
    PubMed     Abstract available


  47. MACHUCA AGUADO J, Sabariego-Arenas I, Idoate MA
    A Pulmonary Inflammatory Chondroid Hamartoma With So-called Placental Transmogrification Feature in a Pleural Location. Pathogenic Considerations About This Unusual Disorder.
    Arch Bronconeumol. 2022;58:363.
    PubMed    


  48. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?
    Arch Bronconeumol. 2022;58:364-366.
    PubMed    


  49. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:345-351.
    PubMed     Abstract available


  50. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    The ANTES program in COPD: First year.
    Arch Bronconeumol. 2022;58:291-294.
    PubMed    


  51. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:T345-T351.
    PubMed     Abstract available


  52. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    [Translated article] Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:T323-T333.
    PubMed     Abstract available


  53. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:323-333.
    PubMed     Abstract available


  54. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:T334-T344.
    PubMed     Abstract available


    March 2022
  55. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    Asthma also exists in older people.
    Arch Bronconeumol. 2022 Mar 11. pii: S0300-2896(22)00183.
    PubMed    


    February 2022
  56. MARTINEZ-GONZALEZ C, Adanez Garcia J, Blanco I
    Term pregnancy of a patient with severe pulmonary emphysema associated with (PI*ZZ) alpha-1 antitrypsin.
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00094.
    PubMed    


  57. BARALDI F, Alfano F, Contoli M, Papi A, et al
    Small Airway Disease in Asthma: Why is it so Important?
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00093.
    PubMed    


  58. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    PubMed     Abstract available


  59. CAZZOLA M, Rogliani P, Matera MG
    The Future of Bronchodilators in COPD and Asthma.
    Arch Bronconeumol. 2022;58:107-108.
    PubMed    


  60. SOLER-CATALUNA JJ, Pinera P, Trigueros JA, Calle M, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome.
    Arch Bronconeumol. 2022;58:T159-T170.
    PubMed     Abstract available


  61. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    PubMed     Abstract available


    January 2022
  62. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
    Arch Bronconeumol. 2022;58:35-51.
    PubMed     Abstract available


    December 2021
  63. MARTINEZ-GARCIA MA, Aksamit TR, Aliberti S
    Bronchiectasis as a Long-Term Consequence of SARS-COVID-19 Pneumonia: Future Studies are Needed.
    Arch Bronconeumol. 2021;57:739-740.
    PubMed    


  64. FIGUEIRA GONCALVES JM, Golpe R, Ramallo Y, Garcia Talavera I, et al
    Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?
    Arch Bronconeumol. 2021;57:774-776.
    PubMed    


  65. CALLE RUBIO M, Rodriguez Hermosa JL, Miravitlles M, Lopez-Campos JL, et al
    Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study.
    Arch Bronconeumol. 2021;57:741-749.
    PubMed     Abstract available


  66. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021;57:731-732.
    PubMed    


    November 2021
  67. OJANGUREN I, Satia I, Usmani OS
    The Role of Viral Infections on Severe Asthma Exacerbations: Present and Future.
    Arch Bronconeumol. 2021 Nov 1. pii: S0300-2896(21)00350.
    PubMed    


  68. LOPEZ-ALBA A, Aldao-Arguelles I, de Granda-Orive JI
    Plastic bronchitis and Noonan syndrome.
    Arch Bronconeumol. 2021;57:705.
    PubMed    


  69. FERREIRO A, Granados G, Villar A
    Peribronchovascular emphysema. The Macklin effect.
    Arch Bronconeumol. 2021;57:697.
    PubMed    


  70. DE-TORRES JP, Wisnivesky JP
    Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
    Arch Bronconeumol. 2021;57:679-680.
    PubMed    


  71. MARTINEZ-GARCIA MA
    Bronchiectasis and Eosinophils.
    Arch Bronconeumol. 2021;57:671-672.
    PubMed    


    October 2021
  72. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
    Arch Bronconeumol. 2021;57:662-664.
    PubMed    


  73. RUANO-RAVINA A, Cameselle-Lago C, Torres-Duran M, Pando-Sandoval A, et al
    Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.
    Arch Bronconeumol. 2021;57:630-636.
    PubMed     Abstract available


  74. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021;57:621-622.
    PubMed    


  75. COHEN M, Casas A, Zabert G, Torres-Duque CA, et al
    Updated Strategic Plan of the Latin American Thoracic Association (ALAT). "The ten commandments for 2021-2026 quinquennial".
    Arch Bronconeumol. 2021;57:617-620.
    PubMed    


  76. MARTINEZ-VERGARA A, Giron RM, Churruca-Arrospide M, Lopez-Pereira P, et al
    Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation.
    Arch Bronconeumol. 2021;57:664-666.
    PubMed    


    September 2021
  77. ALCARAZ-SERRANO V, Lee AL, Gimeno-Santos E
    Respiratory Physiotherapy and Bronchiectasis.
    Arch Bronconeumol. 2021 Sep 14. pii: S0300-2896(21)00316.
    PubMed    


  78. BLANCO-CONDE S, Gonzalez-Cortes C, Lopez-Medrano R, Carazo-Fernandez L, et al
    Mycobacterium abscessus Infected Neutrophils as an In Vitro Model for Bronchiectasis. Neutrophils Prevent Mycobacterial Aggregation.
    Arch Bronconeumol. 2021 Sep 4. pii: S0300-2896(21)00231.
    PubMed    


  79. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D supplementation: A treatment with possible benefits in asthma.
    Arch Bronconeumol. 2021;57:567-568.
    PubMed    


  80. GOLPE R, Dacal-Rivas D, Blanco-Cid N, Castro-Anon O, et al
    Need for Epidemiological Studies on Chronic Obstructive Pulmonary Disease in Rural Spain.
    Arch Bronconeumol. 2021;57:614-615.
    PubMed    


  81. CARRASCO HERNANDEZ L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, et al
    Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow.
    Arch Bronconeumol. 2021;57:593-594.
    PubMed    


  82. COSIO BG, Shafiek H, Verdu J, Fiorentino F, et al
    Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: A Controlled Prospective Study.
    Arch Bronconeumol. 2021;57:577-583.
    PubMed     Abstract available


  83. ALONSO-PEREZ T, Garcia-Castillo E, Lopez-Campos JL
    Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
    Arch Bronconeumol. 2021;57:604-605.
    PubMed    


  84. LOPEZ-CAMPOS JL, Calle Rubio M, Izquierdo Alonso JL, Fernandez-Villar A, et al
    Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD.
    Arch Bronconeumol. 2021;57:596-599.
    PubMed    


    August 2021
  85. EZPONDA A, Casanova C, Cabrera C, Martin-Palmero A, et al
    Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
    Arch Bronconeumol. 2021;57:533-539.
    PubMed     Abstract available


  86. MOROLI RG, Santos DOD, Souza HCD, Perossi L, et al
    Effects of Controlled Voluntary Increase in the Ventilatory Demand on Respiratory System Resistance in Healthy and Non-Cystic Fibrosis Bronchiectasis Subjects: A Cross-Sectional Study.
    Arch Bronconeumol. 2021;57:528-532.
    PubMed     Abstract available


  87. GARCIA-SANZ MT, Gonzalez-Barcala FJ
    COPD is more than just lung function: Let's not forget depression.
    Arch Bronconeumol. 2021;57:519-520.
    PubMed    


    July 2021
  88. MCDONALD VM, Gibson PG
    Treatable Traits in Asthma and COPD.
    Arch Bronconeumol. 2021 Jul 16. pii: S0300-2896(21)00206.
    PubMed    


  89. LOPEZ-VILLARRUBIA E, Costa Estirado O, Iniguez Hernandez C, Ballester Diez F, et al
    Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?
    Arch Bronconeumol. 2021;57:464-470.
    PubMed     Abstract available


    June 2021
  90. MARCHIORI E, Souza Rodrigues R, Menna Barreto M
    Exuberant Paraseptal Emphysema Associated With Pulmonary Alveolar Microlithiasis: 12 Years of Evolution.
    Arch Bronconeumol. 2021 Jun 24. pii: S0300-2896(21)00196.
    PubMed    


    April 2021
  91. SAWAMURA MVY, Athanazio RA, Nucci MCNTM, Rached SZ, et al
    Automated Computed Tomography Lung Densitometry in Bronchiectasis Patients.
    Arch Bronconeumol. 2021 Apr 25. pii: S0300-2896(21)00136.
    PubMed    


    January 2021
  92. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
    [Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19].
    Arch Bronconeumol. 2021;57:13-14.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: